Truist Financial’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,473
Closed -$258K 2984
2026
Q1
$258K Buy
22,473
+38
+0.2% +$535 ﹤0.01% 2487
2025
Q4
$322K Sell
22,435
-591
-3% -$10.2K ﹤0.01% 2284
2025
Q3
$436K Buy
+23,026
New +$379K ﹤0.01% 2104
2023
Q2
Sell
-50,035
Closed -$327K 2644
2023
Q1
$327K Buy
50,035
+11,218
+29% +$45.8K ﹤0.01% 2222
2022
Q4
$95.5K Sell
38,817
-3,663
-9% -$11.4K ﹤0.01% 2486
2022
Q3
$212K Buy
42,480
+8,654
+26% +$50.5K ﹤0.01% 2275
2022
Q2
$144K Buy
33,826
+3,680
+12% +$23.4K ﹤0.01% 2502
2022
Q1
$301K Buy
30,146
+7,496
+33% +$55.8K ﹤0.01% 2322
2021
Q4
$178K Buy
22,650
+7,785
+52% +$97.7K ﹤0.01% 2616
2021
Q3
$259K Buy
+14,865
New +$252K ﹤0.01% 2437

Other funds holding OSCR

Truist Financial's OSCR Position: Q2 2026 in Review

Truist Financial sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 22,473 shares — an estimated $258K sold.

Truist Financial first reported a position in OSCR in Q3 2021 and held it in 10 quarters. The position peaked at $436K in Q3 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Truist Financial reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 22,473 Oscar Health shares in Q2 2026, an estimated $258K.
  • Truist Financial first reported a position in Oscar Health in Q3 2021 and held it in 10 quarters.
  • Truist Financial's Oscar Health position peaked at $436K in Q3 2025.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.